back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2026-04-30 12:54 Tx date 2026-04-28 |
$MDMA
Pharmala Biotech Holdings Inc. |
Kazemzadeh, Farnoud
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+267 vol |
1,553 | |
| Filed 2026-04-30 12:53 Tx date 2026-04-28 |
$MDMA
Pharmala Biotech Holdings Inc. |
Kazemzadeh, Farnoud
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+1,286 vol |
1,286 | |
| Filed 2026-04-28 13:59 Tx date 2025-10-01 |
$MDMA
Pharmala Biotech Holdings Inc. |
Kazemzadeh, Farnoud
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-04-23 15:36 Tx date 2026-04-20 |
$MDMA
Pharmala Biotech Holdings Inc. |
Kazemzadeh, Farnoud
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+1,000,000 vol |
2,000,000 | |
| Filed 2025-10-06 18:46 Tx date 2025-10-03 |
$MDMA
Pharmala Biotech Holdings Inc. |
Kazemzadeh, Farnoud
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+1,000,000 vol |
1,000,000 | |
| Filed 2025-10-06 18:45 Tx date 2025-10-01 |
$MDMA
Pharmala Biotech Holdings Inc. |
Kazemzadeh, Farnoud
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|